Global implementation of genomic medicine: We are not alone

Science Translational Medicine

Volumn 7, Issue 290, 2015, Pages

  Manolio, Teri A ^a   Abramowicz, Marc ^b   Al Mulla, Fahd ^c   Anderson, Warwick ^d   Balling, Rudi ^e   Berger, Adam C ^f   Bleyl, Steven ^g   Chakravarti, Aravinda ^h   Chantratita, Wasun ⁱ   Chisholm, Rex L ^j   Dissanayake, Vajira H W ^k   Dunn, Michael ^l   Dzau, Victor J ^m   Han, Bok Ghee ⁿ   Hubbard, Tim ^o,ao   Kolbe, Anne ^p   Korf, Bruce ^q   Kubo, Michiaki ^r   Lasko, Paul ^s   Leego, Erkki ^t   Mahasirimongkol, Surakameth ^u   Majumdar, Partha P ^v   Matthijs, Gert ^w   McLeod, Howard L ^x   Metspalu, Andres ^t   Meulien, Pierre ^y   Miyano, Satoru ^z   Naparstek, Yaakov ^aa   O'Rourke, P Pearl ^ab   Patrinos, George P ^ac   Rehm, Heidi L ^ab   Relling, Mary V ^ad   Rennert, Gad ^ae   Rodriguez, Laura Lyman ^a   Roden, Dan M ^af   Shuldiner, Alan R ^ag   Sinha, Sukdeb ^ah   Tan, Patrick ^ai   Ulfendahl, Mats ^aj   Ward, Robyn ^ak   Williams, Marc S ^al   Wong, John E L ^am   Green, Eric D ^a   Ginsburg, Geofrey S ^an   more..

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c KUWAIT UNIVERSITY   (Kuwait)

^d NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^e UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^f INSTITUTE OF MEDICINE   (United States)

^g INTERMOUNTAIN HEALTHCARE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

^j NORTHWESTERN UNIVERSITY   (United States)

^k UNIVERSITY OF COLOMBO   (Sri Lanka)

^l WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^m National Academy of Science   (United States)

ⁿ Korea National Institute of Health   (South Korea)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p National Health Committee   (New Zealand)

^q UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^r RIKEN Center for Integrative Medical Sciences   (Japan)

^s MCGILL UNIVERSITY   (Canada)

^t UNIVERSITY OF TARTU   (Estonia)

^u MINISTRY OF PUBLIC HEALTH   (Thailand)

^v INDIAN STATISTICAL INSTITUTE   (India)

^w UNIVERSITY OF LEUVEN   (Belgium)

^x H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^y Genome Canada   (Canada)

^z UNIVERSITY OF TOKYO   (Japan)

^aa HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^ab PARTNERS HEALTHCARE   (United States)

^ac UNIVERSITY OF PATRAS   (Greece)

^ad ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^ae CARMEL MEDICAL CENTER   (Israel)

^af VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ag UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^ah DEPARTMENT OF BIOTECHNOLOGY   (India)

^ai DUKE NUS MEDICAL SCHOOL   (Singapore)

^aj Swedish Research Council   (Sweden)

^ak UNIVERSITY OF QUEENSLAND   (Australia)

^al GEISINGER HEALTH SYSTEM   (United States)

^am NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^an DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ao GENOMICS ENGLAND   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; GENOMIC MEDICINE; GENOMICS; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; INTERNATIONAL COOPERATION; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL INFORMATICS; MEDICAL PRACTICE; MEDICINE; NATIONAL HEALTH ORGANIZATION; PHARMACOGENOMICS; PRIORITY JOURNAL; RESPONSIBILITY; REVIEW; TEAMWORK; HUMAN GENOME; PERSONALIZED MEDICINE;

GENOME, HUMAN; HUMANS; INTERNATIONALITY; PRECISION MEDICINE;

EID: 84930433702     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aab0194     Document Type: Review

References (44)

1. J. J. McCarthy, H. L. McLeod, G. S. Ginsburg, Genomic medicine: A decade of successes, challenges, and opportunities. Sci. Transl. Med. 5, 189sr4 (2013).
2. T. A. Manolio, R. L. Chisholm, B. Ozenberger, D. M. Roden, M. S. Williams, R. Wilson, D. Bick, E. P. Bottinger, M. H. Brilliant, C. Eng, K. A. Frazer, B. Korf, D. H. Ledbetter, J. R. Lupski, C. Marsh, D. Mrazek, M. F. Murray, P. H. O'Donnell, D. J. Rader, M. V. Relling, A. R. Shuldiner, D. Valle, R. Weinshilboum, E. D. Green, G. S. Ginsburg, Implementing genomic medicine in the clinic: The future is here. Genet. Med. 15, 258-267 (2013).
3. P. J. Embi, P. R. Payne, Evidence generating medicine: Redefning the research-practice relationship to complete the evidence cycle. Med. Care 51 (suppl. 3), S87-S91 (2013).
4. B. Simone, W. Mazzucco, M. R. Gualano, A. Agodi, D. Coviello, F. Dagna Bricarelli, B. Dallapiccola, E. Di Maria, A. Federici, M. Genuardi, L. Varesco, W. Ricciardi, S. Boccia-GENISAP Network, The policy of public health genomics in Italy. Health Policy 110, 214-219 (2013).
5. D. N. Cooper, A. Brand, V. Dolzan, P. Fortina, F. Innocenti, M. T. Lee, M. Macek, F. Al-Mulla, B. Prainsack, A. Squassina, E. Vayena, A. Vozikis, C. M. S. Williams, G. P. Patrinos, Bridging genomics research between developed and developing countries: The Genomic medicine alliance. Pers. Med. 11, 615-623 (2014).
6. E. C. Hayden, Geneticists push for global data-sharing. Nature 498, 16-17 (2013).
7. Select Committee on Science and Technology, House of Lords, Second Report - Genomic Medicine (London, The Stationery Ofce, HL Paper 107-I, 2009), p.104.
8. L. Leitsalu, T. Haller, T. Esko, M. L. Tammesoo, H. Alavere, H. Snieder, M. Perola, P. C. Ng, R. Mägi, L. Milani, K. Fischer, A. Metspalu, Cohort Profle: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int. J. Epidemiol. 11, (2014). 10.1093/ije/dyt268
9. M. J. Landrum, J. M. Lee, G. R. Riley, W. Jang, W. S. Rubinstein, D. M. Church, D. R. Maglott, ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42 (D1), D980-D985 (2014).
10. I. Thiele, N. Swainston, R. M. Fleming, A. Hoppe, S. Sahoo, M. K. Aurich, H. Haraldsdottir, M. L. Mo, O. Rolfsson, M. D. Stobbe, S. G. Thorleifsson, R. Agren, C. Bölling, S. Bordel, A. K. Chavali, P. Dobson, W. B. Dunn, L. Endler, D. Hala, M. Hucka, D. Hull, D. Jameson, N. Jamshidi, J. J. Jonsson, N. Juty, S. Keating, I. Nookaew, N. Le Novère, N. Malys, A. Mazein, J. A. Papin, N. D. Price, E. Selkov, Sr, M. I. Sigurdsson, E. Simeonidis, N. Sonnenschein, K. Smallbone, A. Sorokin, J. H. van Beek, D. Weichart, I. Goryanin, J. Nielsen, H. V. Westerhof, D. B. Kell, P. Mendes, B. Ø. Palsson, A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419-425 (2013).
11. I. Thiele, B. Ø. Palsson, Reconstruction annotation jamborees: A community approach to systems biology. Mol. Syst. Biol. 6, 361 (2010).
12. K. A. Fujita, M. Ostaszewski, Y. Matsuoka, S. Ghosh, E. Glaab, C. Trefois, I. Crespo, T. M. Perumal, W. Jurkowski, P. M. Antony, N. Diederich, M. Buttini, A. Kodama, V. P. Satagopam, S. Eifes, A. Del Sol, R. Schneider, H. Kitano, R. Balling, Integrating pathways of Parkinson's disease in a molecular interaction map. Mol. Neurobiol. 49, 88-102 (2014).
13. R. Lakshminarayanan, E. N. Vithana, S. M. Chai, S. S. Chaurasia, P. Saraswathi, A. Venkatraman, C. Rojare, D. Venkataraman, D. Tan, T. Aung, R. W. Beuerman, J. S. Mehta, A novel mutation in transforming growth factor-beta induced protein (TGFßIp) reveals secondary structure perturbation in lattice corneal dystrophy. Br. J. Ophthalmol. 95, 1457-1462 (2011).
14. W. Rattanavipapong, T. Koopitakkajorn, N. Praditsitthikorn, S. Mahasirimongkol, Y. Teerawattananon, Economic evaluation of HLA-B∗15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Epilepsia 54, 1628-1638 (2013).
15. D. Dong, C. Sung, E. A. Finkelstein, Cost-efectiveness of HLA-B∗1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology 79, 1259-1267 (2012).
16. D. S. Toh, L. L. Tan, D. C. Aw, S. M. Pang, S. H. Lim, T. Thirumoorthy, H. Y. Lee, Y. K. Tay, S. K. Tan, A. Vasudevan, A. Lateef, Y. Y. Chong, Y. C. Chan, C. Loke, C. L. Chan, E. S. Koay, E. C. Ren, E. J. Lee, C. Sung, Building pharmacogenetics into a pharmacovigilance program in Singapore: Using serious skin rash as a pilot study. Pharmacogenomics J. 14, 316-321 (2014).
17. I. R. Wiechers, N. C. Perin, R. Cook-Deegan, The emergence of commercial genomics: Analysis of the rise of a biotechnology subsector during the Human Genome Project, 1990 to 2004. Genome Med. 5, 83 (2013).
18. T. Caulfeld, S. H. Harmon, Y. Joly, Open science versus commercialization: A modern research confict? Genome Med. 4, 17 (2012).
19. O. Gottesman, H. Kuivaniemi, G. Tromp, W. A. Faucett, R. Li, T. A. Manolio, S. C. Sanderson, J. Kannry, R. Zinberg, M. A. Basford, M. Brilliant, D. J. Carey, R. L. Chisholm, C. G. Chute, J. J. Connolly, D. Crosslin, J. C. Denny, C. J. Gallego, J. L. Haines, H. Hakonarson, J. Harley, G. P. Jarvik, I. Kohane, I. J. Kullo, E. B. Larson, C. McCarty, M. D. Ritchie, D. M. Roden, M. E. Smith, E. P. Böttinger, M. S. Williamse, MERGE Network, The Electronic Medical Records and Genomics (eMERGE) Network: Past, present, and future. Genet. Med. 15, 761-771 (2013).
20. A. Sommer, Preventing blindness and saving lives: The centenary of vitamin A. JAMA Ophthalmol. 132, 115-117 (2014).
21. R. J. Berry, Z. Li, J. D. Erickson, S. Li, C. A. Moore, H. Wang, J. Mulinare, P. Zhao, L. Y. Wong, J. Gindler, S. X. Hong, A. Correa, Collaborative Project for Neural Tube Defect Prevention, Prevention of neural-tube defects with folic acid in China. China-U.S. N. Engl. J. Med. 341, 1485-1490 (1999).
22. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2, 349-360 (1988).
23. C. J. Murray, M. Ezzati, A. D. Flaxman, S. Lim, R. Lozano, C. Michaud, M. Naghavi, J. A. Salomon, K. Shibuya, T. Vos, A. D. Lopez, GBD 2010: A multi-investigator collaboration for global comparative descriptive epidemiology. Lancet 380, 2055-2058 (2012).
24. D. Avila, K. N. Althof, C. Mugglin, K. Wools-Kaloustian, M. Koller, F. Dabis, D. Nash, T. Gsponer, S. Sungkanuparph, C. McGowan, M. May, D. Cooper, C. Chimbetete, M. Wolf, A. Collier, H. McManus, M. A. Davies, D. Costagliola, B. Crabtree-Ramirez, R. Chaiwarith, A. Cescon, M. Cornell, L. Diero, P. Phanuphak, A. Sawadogo, J. Ehmer, S. P. Eholie, P. C. Li, M. P. Fox, N. R. Gandhi, E. González, C. K. Lee, C. J. Hofmann, A. Kambugu, O. Keiser, R. Ditangco, H. Prozesky, F. Lampe, N. Kumarasamy, M. Kitahata, E. Lugina, R. Lyamuya, S. Vonthanak, V. Fink, A. d'Arminio Monforte, P. M. Luz, Y. M. Chen, A. Minga, J. Casabona, A. Mwango, J. Y. Choi, M. L. Newell, E. A. Bukusi, K. Ngonyani, T. P. Merati, J. Otieno, M. B. Bosco, S. Phiri, O. T. Ng, K. Anastos, J. Rockstroh, I. Santos, S. Oka, G. Somi, C. Stephan, R. Teira, D. Wabwire, G. Wandeler, A. Boulle, P. Reiss, R. Wood, B. H. Chi, C. Williams, J. A. Sterne, M. EggerIe, DEA and ART Cohort Collaborations, Immunodefciency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J. Acquir. Immune Defc. Syndr. 65, e8-e16 (2014).
25. D. A. Zarin, T. Tse, R. J. Williams, R. M. Calif, N. C. Ide, The ClinicalTrials.gov results database - Update and key issues. N. Engl. J. Med. 364, 852-860 (2011).
26. M. S. Lauer, Time for a creative transformation of epidemiology in the United States. JAMA 308, 1804-1805 (2012).
27. G. Ginsburg, Medical genomics: Gather and use genetic data in health care. Nature 508, 451-453 (2014).
28. T. B. Ferguson Jr., E. D. Peterson, L. P. Coombs, M. C. Eiken, M. L. Carey, F. L. Grover, E. R. DeLong, Society of Thoracic Surgeons and the National Cardiac Database, Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: A randomized controlled trial. JAMA 290, 49-56 (2003).
29. J. Starren, M. S. Williams, E. P. Bottinger, Crossing the omic chasm: A time for omic ancillary systems. JAMA 309, 1237-1238 (2013).
30. C. L. Overby, I. Kohane, J. L. Kannry, M. S. Williams, J. Starren, E. Bottinger, O. Gottesman, J. C. Denny, C. Weng, P. Tarczy-Hornoch, G. Hripcsak, Opportunities for genomic clinical decision support interventions. Genet. Med. 15, 817-823 (2013).
31. E. M. Ramos, C. Din-Lovinescu, J. S. Berg, L. D. Brooks, A. Duncanson, M. Dunn, P. Good, T. J. Hubbard, G. P. Jarvik, C. O'Donnell, S. T. Sherry, N. Aronson, L. G. Biesecker, B. Blumberg, N. Calonge, H. M. Colhoun, R. S. Epstein, P. Flicek, E. S. Gordon, E. D. Green, R. C. Green, M. Hurles, K. Kawamoto, W. Knaus, D. H. Ledbetter, H. P. Levy, E. Lyon, D. Maglott, H. L. McLeod, N. Rahman, G. Randhawa, C. Wicklund, T. A. Manolio, R. L. Chisholm, M. S. Williams, Characterizing genetic variants for clinical action. Am. J. Med. Genet. C. Semin. Med. Genet. 166C, 93-104 (2014).
32. H. V. Firth, S. M. Richards, A. P. Bevan, S. Clayton, M. Corpas, D. Rajan, S. Van Vooren, Y. Moreau, R. M. Pettett, N. P. Carter, DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am. J. Hum. Genet. 84, 524-533 (2009).
33. B. R. Korf, A. B. Berry, M. Limson, A. J. Marian, M. F. Murray, P. P. O'Rourke, E. R. Passamani, M. V. Relling, J. Tooker, G. J. Tsongalis, L. L. Rodriguez, Framework for development of physician competencies in genomic medicine: Report of the competencies working group of the inter-society coordinating committee for physician education in genomics. Genet. Med. 16, 804-809 (2014).
34. T. A. Reydon, K. Kampourakis, G. P. Patrinos, Genetics, genomics and society: The responsibilities of scientists for science communication and education. Pers. Med. 9, 633-643 (2012).
35. D. F. Carr, A. Alfrevic, M. Pirmohamed, Pharmacogenomics: Current State-of-the-Art. Genes (Basel) 5, 430-443 (2014).
36. C. Sukasem, A. Puangpetch, S. Medhasi, W. Tassaneeyakul, Pharmacogenomics of drug-induced hypersensitivity reactions: Challenges, opportunities and clinical implementation. Asian Pac. J. Allergy Immunol. 32, 111-123 (2014).
37. A. L. Holden, J. L. Contreras, S. John, M. R. Nelson, The international serious adverse events consortium. Nat. Rev. Drug Discov. 13, 795-796 (2014).
38. M. Pirmohamed, G. Burnside, N. Eriksson, A. L. Jorgensen, C. H. Toh, T. Nicholson, P. Kesteven, C. Christersson, B. Wahlström, C. Stafberg, J. E. Zhang, J. B. Leathart, H. Kohnke, A. H. Maitland-van der Zee, P. R. Williamson, A. K. Daly, P. Avery, F. Kamali, M. Wadelius, EU-PACT Group, A randomized trial of genotype-guided dosing of warfarin. N. Engl. J. Med. 369, 2294-2303 (2013).
39. J. M. Pulley, J. C. Denny, J. F. Peterson, G. R. Bernard, C. L. Vnencak-Jones, A. H. Ramirez, J. T. Delaney, E. Bowton, K. Brothers, K. Johnson, D. C. Crawford, J. Schildcrout, D. R. Masys, H. H. Dilks, R. A. Wilke, E. W. Clayton, E. Shultz, M. Laposata, J. McPherson, J. N. Jirjis, D. M. Roden, Operational implementation of prospective genotyping for personalized medicine: The design of the Vanderbilt PREDICT project. Clin. Pharmacol. Ther. 92, 87-95 (2012).
40. M. A. Martin, D. L. Kroetz, Abacavir pharmacogenetics - From initial reports to standard of care. Pharmacotherapy 33, 765-775 (2013).
41. C. Mizzi, B. Peters, C. Mitropoulou, K. Mitropoulos, T. Katsila, M. R. Agarwal, R. H. van Schaik, R. Drmanac, J. Borg, G. P. Patrinos, Personalized pharmacogenomics profling using whole-genome sequencing. Pharmacogenomics 15, 1223-1234 (2014).
42. K. Kampourakis, E. Vayena, C. Mitropoulou, R. H. van Schaik, D. N. Cooper, J. Borg, G. P. Patrinos, Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs. EMBO Rep. 15, 472-476 (2014).
43. B. M. Knoppers, I. Fortier, D. Legault, P. Burton, The Public Population Project in Genomics (P3G): A proof of concept? Eur. J. Hum. Genet. 16, 664-665 (2008).
44. S. R. Snyder, C. Mitropoulou, G. P. Patrinos, M. S. Williams, Economic evaluation of pharmacogenomics: A value-based approach to pragmatic decision making in the face of complexity. Public Health Genomics 17, 256-264 (2014).